Conversion of Hodgkin's disease to lymphoblastic lymphosarcoma.
D000368:Aged; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008099:Liver / Q000473:pathology; D008197:Lymph Node Excision; D008220:Lymphography; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology*; D009378:Neoplasms, Multiple Primary; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D013156:Splenectomy; D014750:Vincristine / Q000627:therapeutic use
D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone